Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,027 | 832 | 99.5% |
| Education | $76.46 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,748 | 151 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,728 | 163 | $0 (2024) |
| ABBVIE INC. | $1,924 | 101 | $0 (2024) |
| PFIZER INC. | $917.67 | 88 | $0 (2023) |
| Janssen Biotech, Inc. | $692.97 | 48 | $0 (2023) |
| Genentech USA, Inc. | $649.47 | 36 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $648.04 | 31 | $0 (2020) |
| Lilly USA, LLC | $622.66 | 38 | $0 (2022) |
| Celgene Corporation | $426.51 | 22 | $0 (2019) |
| GlaxoSmithKline, LLC. | $280.28 | 31 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $636.96 | 43 | Novartis Pharmaceuticals Corporation ($353.39) |
| 2023 | $753.56 | 45 | Novartis Pharmaceuticals Corporation ($254.20) |
| 2022 | $820.07 | 60 | ABBVIE INC. ($344.25) |
| 2021 | $855.19 | 48 | Novartis Pharmaceuticals Corporation ($295.28) |
| 2020 | $742.90 | 40 | Amgen Inc. ($314.64) |
| 2019 | $3,648 | 219 | Amgen Inc. ($682.11) |
| 2018 | $3,755 | 216 | Amgen Inc. ($683.90) |
| 2017 | $2,893 | 165 | Amgen Inc. ($405.97) |
All Payment Transactions
836 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,573 | 75,152 | $2.4M | $748,763 |
| 2022 | 17 | 1,285 | 76,122 | $2.2M | $700,251 |
| 2021 | 17 | 1,294 | 68,119 | $2.1M | $712,394 |
| 2020 | 17 | 1,072 | 16,683 | $924,374 | $323,667 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 15 | $4,380 | $722.73 | 16.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $2,139 | $584.18 | 27.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 25 | 152 | $608.00 | $152.01 | 25.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 23 | 31 | $465.00 | $142.07 | 30.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 160 | 14,820 | $611,460 | $230,564 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 296 | 550 | $143,850 | $45,670 | 31.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 56 | 66 | $23,350 | $7,787 | 33.4% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 145 | 145 | $26,416 | $6,423 | 24.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 25 | 98 | $18,548 | $5,902 | 31.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 173 | 502 | $30,123 | $5,859 | 19.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 14 | 47 | $19,699 | $5,752 | 29.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $11,648 | $4,402 | 37.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 30 | 35 | $7,630 | $2,981 | 39.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 28 | 46 | $11,180 | $2,651 | 23.7% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2020 | 14 | 86 | $9,804 | $2,287 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 31 | $5,488 | $1,501 | 27.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $1,635 | $914.70 | 55.9% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2020 | 11 | 11 | $1,441 | $413.58 | 28.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 16 | 16 | $1,104 | $284.48 | 25.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 25 | 167 | $668.00 | $168.15 | 25.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 13 | 22 | $330.00 | $106.87 | 32.4% |
About Dr. Susan Lemon, DO
Dr. Susan Lemon, DO is a Rheumatology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972645513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Lemon, DO has received a total of $14,104 in payments from pharmaceutical and medical device companies, with $636.96 received in 2024. These payments were reported across 836 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($14,027).
As a Medicare-enrolled provider, Lemon has provided services to 5,224 Medicare beneficiaries, totaling 236,076 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Santa Barbara, CA
- Active Since 02/12/2007
- Last Updated 01/31/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1972645513
Products in Payments
- COSENTYX (Biological) $2,022
- Enbrel (Biological) $1,780
- Humira (Biological) $714.55
- XELJANZ (Drug) $621.28
- COSENTYX (Drug) $607.59
- RINVOQ (Biological) $568.75
- TALTZ (Drug) $532.76
- Rituxan (Biological) $529.62
- SIMPONI ARIA (Biological) $517.53
- ORENCIA (Biological) $404.53
- Prolia (Biological) $355.74
- BENLYSTA (Biological) $280.28
- EVENITY (Biological) $274.87
- ACTHAR (Biological) $261.63
- SKYRIZI (Biological) $229.58
- Rinvoq (Biological) $228.89
- KRYSTEXXA (Drug) $209.98
- MONOVISC (Device) $205.34
- KRYSTEXXA (Biological) $179.80
- KEVZARA (Drug) $179.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Barbara
Stuart Segal, M.d, M.D
Rheumatology — Payments: $162,377
Hans Richard Barthel, M.d, M.D
Rheumatology — Payments: $32,207
Christian Powell
Rheumatology — Payments: $21,653
Sara Taroumian, M.d, M.D
Rheumatology — Payments: $17,319
Dr. Timothy Spiegel, M.d, M.D
Rheumatology — Payments: $12,362
Guy Clark, Md, MD
Rheumatology — Payments: $3,579